Ophthalmic devices are those devices which are used for vision correction or in ophthalmic diagnostic procedures. Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. GlobalData uses proprietary data and analytics to provide a comprehensive report on the glaucoma surgery devices devices market, including market shares of different players within France. Buy the latest report here.

Smarter leaders trust GlobalData


Data Insights France Glaucoma Surgery Devices Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2021, GlobalData’s Market Model methodology determined that the leading player in the glaucoma surgery devices market in France was Glaukos followed by New World Medical, Allergan Aesthetics, Ivantis, Johnson & Johnson Vision Care, Santen Pharmaceutical and Aurolab.

Glaucoma drainage devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow. This category includes glaucoma drainage devices and Minimally Invasive Glaucoma Surgery (MIGS).

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the glaucoma surgery devices devices market within France was expected to be over $10m in 2021.

For the latest complete market share analysis of glaucoma surgery devices device market in France, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.